Well Lead Medical Co., Ltd. (603309.SS)
CNY 11.66
(0.6%)
CNY 11.66
(0.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 233.51 Million | 391.12 Million | 187.28 Million | 228.44 Million | 178.79 Million | 89.88 Million |
| Net Income | 192.48 Million | 177.75 Million | 114.67 Million | 159.87 Million | 124.49 Million | 56.44 Million |
| Depreciation & Amortization | 72.16 Million | 65.51 Million | 57.74 Million | 48.55 Million | 42.57 Million | 28.91 Million |
| Deferred income taxes | -35.23 Thousand | 8948.08 | -2.74 Million | 889.11 Thousand | -3.09 Million | -1.23 Million |
| Stock-based compensation | 3.37 Million | 16.44 Million | 1.39 Million | - | - | - |
| Change in working capital | -69.91 Million | 107.48 Million | -9.53 Million | -12.81 Million | -4.86 Million | 1.88 Million |
| Other non-cash items | 255.65 Million | 23 Million | 25.75 Million | 32.83 Million | 16.58 Million | 2.65 Million |
| Investing Cash Flow | -335.45 Million | -559.93 Million | -156.34 Million | -95.74 Million | -92.01 Million | -314.6 Million |
| Investments in PPE | -357.88 Million | -181.37 Million | -109.28 Million | -92.48 Million | -112.53 Million | -78.66 Million |
| Acquisitions | 344.05 Thousand | 1.58 Million | -33.44 Million | -278 Thousand | -16.33 Million | -480.4 Million |
| Investment purchases | -1.46 Billion | -1.57 Billion | -211 Million | -217 Million | -355 Million | -1.09 Billion |
| Sales/Maturities of investments | 1.48 Billion | 1.19 Billion | 194.43 Million | 216.15 Million | 371.43 Million | 1.34 Billion |
| Other Investing Activities | 6.9 Million | -1.49 Million | 2.93 Million | -2.13 Million | 20.41 Million | 90.21 Thousand |
| Financing Cash Flow | 11.66 Million | -46.9 Million | 413.87 Million | -137.9 Million | -64.21 Million | 238.34 Million |
| Debt repayment | -132.73 Million | -155.74 Million | -70 Million | -91 Million | -72.5 Million | -2.5 Million |
| Dividends payments | -99.65 Million | -39.58 Million | -52 Million | -40 Million | -20 Million | -30 Million |
| Common Stock Repurchased | -1.06 Million | -1.35 Million | 505 Thousand | 520 Thousand | - | - |
| Common Stock Issuance | - | 1.35 Million | -505 Thousand | -520 Thousand | - | - |
| Other Financing Activities | -10.13 Million | 154.32 Million | 542.43 Million | 3.69 Million | 41.97 Million | 273.54 Million |
| Accounts receivables | -74.03 Million | 59.97 Million | -20.32 Million | -3.74 Million | -9.17 Million | -20.7 Million |
| Accounts payables | -6.75 Million | 52.7 Million | 50.48 Million | 21.17 Million | 13.22 Million | 44.04 Million |
| Inventory | 8.27 Million | -5.2 Million | -36.94 Million | -31.13 Million | -5.81 Million | -20.21 Million |
| Other working capital | 2.59 Million | 8948.42 | -2.74 Million | 889.11 Thousand | -3.09 Million | 22.09 Million |
| Cash at beginning of period | 393.02 Million | 604.57 Million | 161.85 Million | 171.1 Million | 149.06 Million | 134.58 Million |
| Cash at end of period | 302.87 Million | 391.43 Million | 604.57 Million | 161.85 Million | 171.1 Million | 149.06 Million |
| Capital Expenditure | -357.88 Million | -181.37 Million | -109.28 Million | -92.48 Million | -112.53 Million | -78.66 Million |
| Effect of forex changes on cash | 1.7 Million | 2.57 Million | -2.09 Million | -4.04 Million | -520.12 Thousand | 854.44 Thousand |
| Net cash flow / Change in cash | -90.14 Million | -213.13 Million | 442.71 Million | -9.25 Million | 22.04 Million | 14.47 Million |
| Free Cash Flow | -124.37 Million | 209.74 Million | 78 Million | 135.95 Million | 66.25 Million | 11.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 60.67 Million | 55.79 Million | 50.25 Million | 192.48 Million | 48.56 Million | 51.83 Million |
| Depreciation & Amortization | - | 18.91 Million | 18.91 Million | 72.16 Million | 18.8 Million | -34.16 Million |
| Deferred income taxes | - | - | - | -35.23 Thousand | 59.79 Million | - |
| Stock-based compensation | - | - | - | 3.37 Million | 3.37 Million | - |
| Change in working capital | - | -46.62 Million | - | -69.91 Million | -63.16 Million | 27 Million |
| Other non-cash items | -22.71 Million | 11.28 Million | -11.29 Million | 255.65 Million | 48.09 Million | 241.79 Thousand |
| Investing Cash Flow | 51.72 Million | -79.48 Million | -140.73 Million | -335.45 Million | -176.23 Million | -23.89 Million |
| Investments in PPE | -94.84 Million | -45.28 Million | -73.73 Million | -357.88 Million | -108.32 Million | -128.25 Million |
| Acquisitions | 5000.00 | 14.69 Million | -13 Million | 344.05 Thousand | -265.86 Thousand | 0.64 |
| Investment purchases | -29 Million | -628.11 Million | -198 Million | -1.46 Billion | -485.55 Million | -143 Million |
| Sales/Maturities of investments | 175.56 Million | 579.22 Million | 144 Million | 1.48 Billion | 411 Million | 247.35 Million |
| Other Investing Activities | 5000.00 | -45.97 Million | -53.34 Million | 6.9 Million | 6.9 Million | - |
| Financing Cash Flow | -113.92 Million | -159.78 Million | 271.99 Million | 11.66 Million | 78.22 Million | 53.29 Million |
| Debt repayment | -81.43 Million | -26.96 Million | -277.45 Million | -132.73 Million | -71.43 Million | -87 Million |
| Dividends payments | -29.76 Million | -126.63 Million | -3.62 Million | -99.65 Million | -76.95 Thousand | -30.44 Million |
| Common Stock Repurchased | - | - | - | -1.06 Million | -1.06 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.73 Million | -127.04 Million | -5.46 Million | -10.13 Million | 18 Million | 170.74 Million |
| Accounts receivables | - | -16.71 Million | - | -74.03 Million | -74.03 Million | 30.41 Million |
| Accounts payables | - | - | - | -6.75 Million | - | - |
| Inventory | - | -29.91 Million | - | 8.27 Million | 8.27 Million | -3.41 Million |
| Other working capital | - | - | - | 2.59 Million | 2.59 Million | - |
| Cash at beginning of period | 282.94 Million | 473.36 Million | 302.87 Million | 393.02 Million | 285.8 Million | 211.74 Million |
| Cash at end of period | 256.29 Million | 282.94 Million | 473.36 Million | 302.87 Million | 302.87 Million | 285.8 Million |
| Capital Expenditure | -94.84 Million | -45.28 Million | -73.73 Million | -357.88 Million | -108.32 Million | -128.25 Million |
| Effect of forex changes on cash | -609.72 Thousand | 686.99 Thousand | 279.94 Thousand | 1.7 Million | -394.88 Thousand | -260.33 Thousand |
| Net cash flow / Change in cash | -26.65 Million | -190.42 Million | 170.49 Million | -90.14 Million | 17.07 Million | 74.05 Million |
| Free Cash Flow | -56.89 Million | 2.87 Million | -34.77 Million | -124.37 Million | 7.14 Million | -83.32 Million |
000977
TCBPW
080580
SLFIF
RTMNF
688608